Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
McKinsey
McKesson
Harvard Business School
Julphar
Baxter
Federal Trade Commission
Chubb
Covington

Generated: June 24, 2018

DrugPatentWatch Database Preview

DOXYLAMINE SUCCINATE - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for doxylamine succinate and what is the scope of doxylamine succinate patent protection?

Doxylamine succinate
is the generic ingredient in eight branded drugs marketed by Pfizer, Sanofi Aventis Us, Par Pharm, Copley Pharm, LNK, Perrigo, Quantum Pharmics, Chattem, Duchesnay, Actavis Labs Fl Inc, and Par Pharm Inc, and is included in thirteen NDAs. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for doxylamine succinate. Twenty-eight suppliers are listed for this compound.
Medical Subject Heading (MeSH) Categories for DOXYLAMINE SUCCINATE
Synonyms for DOXYLAMINE SUCCINATE
(Dimethylamino)ethoxy-methyl-benzyl-pyridine succinate
[[[(2-Dimethylamino)ethoxy]phenyl]methyl]-2-picoline succinate
2-(alpha-(2-Dimethylaminoethoxy)-alpha-methylbenzyl)pyridine succinate
2-(alpha(2-(Dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine succinate (1:1)
2-[[.alpha.-(2-Dimethylamino)ethoxy]-.alpha.-methylbenzyl]pyridine succinate
2-[a-[2-(Dimethylamino)ethoxy]-a-methylbenzyl]pyridine succinate
2-Dimethylaminoethoxyphenylmethyl-2-picoline succinate
2-Dimethylaminoethoxyphenylmethyl-2-picoline succinate (1:1)
562-10-7
A-H Injection
AB0017830
AC-4487
AC1L1WW1
AC1Q5VR4
ACM1216840946
AI3-23993
AKOS025310916
alpha-(2-Dimethylaminoethoxy)-alpha-methyl-alpha-phenyl-2-picoline acid succinate
Alsadorm
AN-11902
API0002494
AS-13661
BC678008
BG0679
Butanedioic acid, compd. with N,N-dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine
Butanedioic acid, compd. with N,N-dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine (1:1)
Butanedioic acid, compd. with N,N-dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine (1:1) (9CI)
Butanedioic acid, compd. with N,N-dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]ethanamine (1:1)
Butanedioic acid,N-dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]ethanamine (1:1)
butanedioic acid,N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine
butanedioic acid; N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine
butanedioic acid;N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine
C17H22N2O.C4H6O4
C19414
C21H28N2O5
CAS-562-10-7
CCG-101033
CCG-38929
CCRIS 4811
CHEBI:82461
CHEMBL1200392
CPD000058436
CS-3232
D 3775
D-9200
D02327
Decapryn
Decapryn (TN)
Decapryn Succinate
Decapryn succinate (1:1)
Decarpyn succinate (1:1)
Dimethylaminoethoxy-methyl-benzyl-pyridine succinate
Doxy-sleep-aid
Doxylamine (succinate)
Doxylamine for system suitability, European Pharmacopoeia (EP) Reference Standard
Doxylamine hydrogen succinate
Doxylamine Hydrogen Succinate 1.0 mg/ml in Methanol (as free base)
Doxylamine hydrogen succinate, European Pharmacopoeia (EP) Reference Standard
Doxylamine succinate (1:1)
Doxylamine succinate (USP)
Doxylamine succinate [USP]
Doxylamine succinate liquid
Doxylamine succinate salt
Doxylamine Succinate, pharmaceutical secondary standard; traceable to USP, PhEur
Doxylamine succinate, United States Pharmacopeia (USP) Reference Standard
Doxylamine-d5 Succinate
doxylamine; succinic acid
DSSTox_CID_552
DSSTox_GSID_20552
DSSTox_RID_75656
DTXSID7020552
EINECS 209-228-7
EQUALINE SLEEP AID
Ethanamine, N,N-dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)-, butanedioate (1:1)
EU-0100348
Evigoa D
F2173-1155
FT-0082833
FT-0625595
Gittalun
HE009961
HMS1568E15
HMS1920K04
HMS2051F14
HMS2091B09
HMS2095E15
HMS2231G05
HMS3261E17
HMS3370K04
HMS3393F14
HMS3652H19
HMS502K03
Hoggar N
HY-A0069
J10070
KB-295989
LP00348
LS-1380
Mereprine
MFCD00056168
MLS000028417
MLS000758288
MLS001076141
MLS001424137
MLS002222274
MolPort-003-666-172
N,N-dimethyl-2-(1-phenyl-1-(pyridin-2-yl)ethoxy)ethanamine succinate
n,n-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine butanedioate
N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine succinate
N,N-Dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]ethenamine succinate
N,N-dimethyl-2-[1-phenyl-1-(2-pyridyl)ethoxy]ethanamine; succinic acid
N,N-dimethyl-2-[1-phenyl-1-pyridin-2-ylethoxy]ethanamine succinate
NC00283
NCGC00016140-02
NCGC00016140-03
NCGC00016140-04
NCGC00017028-02
NCGC00021147-11
NCGC00089789-03
NCGC00093785-01
NCGC00093785-02
NCGC00093785-03
NCGC00256517-01
NCGC00259627-01
NCGC00261033-01
NSC 74772
NSC-74772
NSC-756752
NSC74772
NSC756752
Opera_ID_566
Pharmakon1600-01500267
Phenyl2-pyridylmethyl-(.beta.-N,N-dimethylamino)ethyl ether succinate
Phenyl2-pyridylmethyl-beta-N,N-dimethylaminoethyl ether succinate
Prestwick_887
Pyridine, 2-(alpha-(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)-, succinate (1:1)
Pyridine, succinate (1:1)
Q835
s4240
Safetussin
SAM001247030
SCHEMBL160443
Sedaplus
SMR000058436
SPECTRUM1500267
Succinic acid, compd. with 2-(alpha-(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine (1:1)
Succinic acid, compd. with 2-(alpha-(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine (1:1) (8CI)
Succinic acid, compd. with 2-[.alpha.-[2-(dimethylamino)ethoxy]-.alpha.-methylbenzyl]pyridine (1:1)
Topcare sleep aid
Tox21_113515
Tox21_113515_1
Tox21_202078
Tox21_302861
Tox21_500348
Unisom
WLN: T6NJ BX1&R&O2N1&1 &OV2VO

US Patents and Regulatory Information for DOXYLAMINE SUCCINATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo DOXYLAMINE SUCCINATE doxylamine succinate TABLET;ORAL 040167-001 Sep 18, 1996 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Duchesnay DICLEGIS doxylamine succinate; pyridoxine hydrochloride TABLET, DELAYED RELEASE;ORAL 021876-001 Apr 8, 2013 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Duchesnay BONJESTA doxylamine succinate; pyridoxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 209661-001 Nov 7, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Duchesnay BONJESTA doxylamine succinate; pyridoxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 209661-001 Nov 7, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cantor Fitzgerald
Teva
Fish and Richardson
Covington
Chinese Patent Office
Moodys
Deloitte
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.